CD28 and metabolic dysfunction-associated steatohepatitis: As shown in Fig. 3a, b, the participants with T2D and NASH or liver cirrhosis had greater numbers of CD28 − CD57+ senescent CD4+ and CD8 + T cells in their livers than the healthy controls.